Robert Chess, Director: Nektar Therapeutics NKTR Sell · Filed 24/06/14

Trade details

Type: Insider sale
Amount: $23,400
Shares · price: 19,500 sh · $1.20 a share
Held after: 255,273 sh
Stock: Nektar Therapeutics NKTR
Person: Robert ChessDirector
Trade date: 24/06/14
Filed: 24/06/14
Days to filing: 0 days

Sold 7.1% of holdings

Share of holding sold: 7.1%

Nektar Therapeutics trades, last 26 weeks

What else happened in Nektar Therapeutics around then

Filed or reported within 30 days of the trade day · 24/05/15~24/07/14

Robert Chess's recent trades

Robert ChessDirector
Planned sale10b5-1 planTwist Bioscience
Planned sale10b5-1 plan
Twist Bioscience
TWST
$2M
18,417 sh
$2M
Filed 08/07
Traded 08/07
Robert ChessDirector
Sell10b5-1 planTwist Bioscience
Sell10b5-1 plan
Twist Bioscience
TWST
$470K
10,000 sh
$470K
Filed 03/19
Traded 03/17
Robert ChessDirector
Planned sale10b5-1 planTwist Bioscience
Planned sale10b5-1 plan
Twist Bioscience
TWST
$470K
10,000 sh
$470K
Filed 03/17
Traded 03/17
Robert ChessDirector
SellTwist Bioscience
Sell
Twist Bioscience
TWST
$105.4K
2,184 sh
$105.4K
Filed 02/18
Traded 02/13
Robert ChessDirector
Planned saleTwist Bioscience
Planned sale
Twist Bioscience
TWST
$105.4K
2,184 sh
$105.4K
Filed 02/13
Traded 02/13